
Liquidity, historical trends, and peer comparisons.
According to Lucyd, Inc’s latest financial reports and current stock price. The company's current Current Ratio is 12.06. This represents a change of 17.40% compared to the average of 10.27 of the last 4 quarters.
The mean historical Current Ratio of Lucyd, Inc over the last ten years is 5.55. The current 12.06 Current Ratio has changed 117.32% with respect to the historical average. Over the past ten years (40 quarters), LUCY's Current Ratio was at its highest in in the June 2023 quarter at 26.53. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
5.55
Median
7.07
Minimum
0
Maximum
12.52
Discovering the peaks and valleys of Lucyd, Inc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Current Ratio = 12.52
Minimum Annual Increase = -27.92%
Minimum Annual Current Ratio = 0
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 9.03 | -27.92% |
| 2024 | 12.52 | 39.23% |
| 2023 | 8.99 | 27.26% |
| 2022 | 7.07 | 576.59% |
| 2021 | 1.04 | 464.18% |
| 2020 | 0.19 | Infinity% |
The current Current Ratio of Lucyd, Inc (LUCY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
10.18
5-year avg
7.73
10-year avg
5.55
Lucyd, Inc’s Current Ratio is greater than Meihua International Medical Technologies Co., Ltd. (8.42), greater than Check-Cap Ltd. (0.05), greater than BioCardia, Inc. (2.09), less than Creative Medical Technology Holdings, Inc. (12.91), greater than Profusa, Inc. Common Stock (0.03), greater than Kiora Pharmaceuticals, Inc. (8.97), greater than Sunshine Biopharma, Inc. (5.46), greater than Predictive Oncology Inc. (1.45), greater than Aprea Therapeutics, Inc. (9.67), greater than Biomerica, Inc. (1.91),
| Company | Current Ratio | Market cap |
|---|---|---|
| 8.42 | $2.41M | |
| 0.05 | $10.88M | |
| 2.09 | $13.82M | |
| 12.91 | $1.68M | |
| 0.03 | $2.88M | |
| 8.97 | $7.34M | |
| 5.46 | $5.63M | |
| 1.45 | $3.57M | |
| 9.67 | $6.36M | |
| 1.91 | $7.98M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lucyd, Inc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lucyd, Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Lucyd, Inc's Current Ratio?
How is the Current Ratio calculated for Lucyd, Inc (LUCY)?
What is the highest Current Ratio for Lucyd, Inc (LUCY)?
What is the 3-year average Current Ratio for Lucyd, Inc (LUCY)?
What is the 5-year average Current Ratio for Lucyd, Inc (LUCY)?
How does the current Current Ratio for Lucyd, Inc (LUCY) compare to its historical average?